Shanghai Kai Kai Industry Company Limited (SHSE: 600272)
Health Care · Pharmaceuticals · CN
CN¥16.50
-6.25% today · +18.0% 1Y
Shanghai Kai Kai Industry Company Limited (SHSE: 600272) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $482.40M and employs 438 people.
Over the last twelve months the share price has gained 18.0%, trading between 9.79 and 20.93.
Tweenvest scores Shanghai Kai Kai Industry Company Limited across four factors: quality 69/100, value 10/100, growth 28/100, dividend 7/100. Its strongest factor is quality.
600272 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $482.40M
- Revenue (TTM)
- $164.16M
- P/E
- 189.12
- EPS
- 0.09
- Dividend yield
- 0.09%
- Beta (5Y)
- -0.13
- 52-week high
- CN¥20.93
- 52-week low
- CN¥9.79
- Avg volume (3M)
- —
- Shares outstanding
- 262.65M
- Employees
- 438
- Next earnings
- —
About Shanghai Kai Kai Industry Company Limited
Shanghai Kai Kai Industry Company Limited, established in 1993 and based in Shanghai, China, is involved in a range of activities within the Chinese market. The company's operations include the manufacturing, wholesale distribution, and direct retail of various goods, specifically apparel such as shirts and sweaters, as well as a selection of pharmaceuticals, encompassing both traditional Chinese and Western medicines.
- ISIN
- CNE000001766
- Founded
- 1992
- Listed since
- Feb 28, 2001
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.